Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2022 年第 2 季持倉
持倉截至 2022/6/30，2022/8/15 申報。只含多頭部位，變化是跟 2022 年第 1 季比股數。
- 持股檔數
- 82
- 較 2022 年第 1 季 −9
- 總值
- $43.6 億
- 較 2022 年第 1 季 −$1.50 億 (−3.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | 3,499,000 | $2.31 億 | 5.3% | −201,000−5.4% | 減碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 793,000 | $2.23 億 | 5.1% | +247,400+45.3% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 572,500 | $2.17 億 | 5.0% | +396,500+225.3% | 加碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 441,000 | $2.13 億 | 4.9% | +41,600+10.4% | 加碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 6,652,700 | $2.07 億 | 4.7% | +984,400+17.4% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 610,000 | $1.98 億 | 4.5% | +610,000 | 新進 | 歷史 |
| HUMHumana Inc | Stock | 412,300 | $1.93 億 | 4.4% | +213,400+107.3% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 725,600 | $1.71 億 | 3.9% | +6,654+0.9% | 加碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 900,200 | $1.60 億 | 3.7% | +546,200+154.3% | 加碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,856,900 | $1.48 億 | 3.4% | +725,500+64.1% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 1,467,600 | $1.43 億 | 3.3% | +307,600+26.5% | 加碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 3,355,623 | $1.41 億 | 3.2% | +440,323+15.1% | 加碼 | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 1,875,000 | $1.39 億 | 3.2% | +1,435,000+326.1% | 加碼 | – |
| MCKMcKesson Corp | Stock | 388,800 | $1.27 億 | 2.9% | +199,300+105.2% | 加碼 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 242,200 | $1.24 億 | 2.9% | −17,400−6.7% | 減碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 755,000 | $1.16 億 | 2.7% | −711,100−48.5% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 5,450,000 | $1.05 億 | 2.4% | +626,600+13.0% | 加碼 | 歷史 |
| CTLTCatalent, Inc. | COM | 955,000 | $1.02 億 | 2.4% | +173,000+22.1% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 3,585,881 | $1.01 億 | 2.3% | +408,882+12.9% | 加碼 | 歷史 |
| SGENSeagen Inc. | COM | 550,000 | $9,732 萬 | 2.2% | +450,000+450.0% | 加碼 | 歷史 |
| BSXBoston Scientific Corp | Stock | 2,525,000 | $9,411 萬 | 2.2% | +1,328,900+111.1% | 加碼 | 歷史 |
| BIIBBiogen Inc. | COM | 440,566 | $8,985 萬 | 2.1% | +75,566+20.7% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 1,479,500 | $8,827 萬 | 2.0% | +610,500+70.3% | 加碼 | 歷史 |
| ACHCAcadia Healthcare Company, Inc. | COM | 1,035,000 | $7,000 萬 | 1.6% | +1,035,000 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 1,125,194 | $5,824 萬 | 1.3% | +735,119+188.5% | 加碼 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,000,000 | $5,500 萬 | 1.3% | −95,000−8.7% | 減碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 1,438,999 | $5,067 萬 | 1.2% | +483,999+50.7% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 1,350,000 | $5,037 萬 | 1.2% | −13,800−1.0% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 1,369,100 | $4,852 萬 | 1.1% | +69,100+5.3% | 加碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 775,504 | $4,427 萬 | 1.0% | +775,504 | 新進 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,972,947 | $4,103 萬 | 0.9% | +282,947+10.5% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 4,265,000 | $3,941 萬 | 0.9% | +580,000+15.7% | 加碼 | – |
| ALTAltimmune, Inc. | COM NEW | 2,981,000 | $3,488 萬 | 0.8% | +116,000+4.0% | 加碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 4,050,000 | $3,349 萬 | 0.8% | +532,000+15.1% | 加碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 2,080,200 | $3,023 萬 | 0.7% | +35,200+1.7% | 加碼 | – |
| KRTXKaruna Therapeutics, Inc. | COM | 204,570 | $2,588 萬 | 0.6% | +204,570 | 新進 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 1,325,000 | $2,582 萬 | 0.6% | +1,325,000 | 新進 | 歷史 |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 750,000 | $2,362 萬 | 0.5% | +750,000 | 新進 | – |
| VIRVir Biotechnology, Inc. | COM | 758,211 | $1,931 萬 | 0.4% | −21,789−2.8% | 減碼 | 歷史 |
| NKTXNkarta, Inc. | COM | 1,414,082 | $1,742 萬 | 0.4% | +1,414,082 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,919,800 | $1,620 萬 | 0.4% | −26,200−1.3% | 減碼 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 2,950,000 | $1,602 萬 | 0.4% | +130,933+4.6% | 加碼 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 1,200,000 | $1,578 萬 | 0.4% | +1,200,000 | 新進 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 4,855,000 | $1,573 萬 | 0.4% | −60.0% | 減碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,392,300 | $1,537 萬 | 0.4% | −4,650,919−77.0% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 450,000 | $1,369 萬 | 0.3% | +450,000 | 新進 | 歷史 |
| SIBNSI-BONE, Inc. | COM | 1,000,000 | $1,320 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SPNESeaSpine Holdings Corp | COM | 2,010,000 | $1,136 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 1,715,000 | $1,122 萬 | 0.3% | −1,020,600−37.3% | 減碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 215,000 | $972.2 萬 | 0.2% | +5,000+2.4% | 加碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 62,000 | $967.3 萬 | 0.2% | +62,000 | 新進 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 998,565 | $849.8 萬 | 0.2% | −208,435−17.3% | 減碼 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,460,000 | $774.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 865,000 | $726.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ERASErasca, Inc. | COM | 995,000 | $554.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 1,850,000 | $553.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 688,330 | $533.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 2,000,000 | $530.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 520,000 | $508.6 萬 | 0.1% | 00.0% | 不變 | – |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $495.0 萬 | 0.1% | 00.0% | 不變 | – |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $490.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $488.0 萬 | 0.1% | 00.0% | 不變 | – |
| SSentinelOne, Inc. | CL A | 204,500 | $477.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 430,117 | $413.8 萬 | 0.1% | −6,045,283−93.4% | 減碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $398.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 813,640 | $368.6 萬 | 0.1% | +92,640+12.8% | 加碼 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,503,754 | $335.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 755,329 | $274.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PHASPhaseBio Pharmaceuticals Inc | COM | 4,405,000 | $264.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Field Trip Health Ord31656R102 | COM | 2,976,000 | $250.0 萬 | 0.1% | 00.0% | 不變 | – |
| ONCSOncosec Medical Inc | COM | 2,945,000 | $218.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| OTICOtonomy, Inc. | COM | 1,000,000 | $208.0 萬 | <0.1% | −349,905−25.9% | 減碼 | 歷史 |
| PROKProkidney Corp. | CLASS A ORD SHS | 200,000 | $199.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| AKLIAkili, Inc. | CLASS A ORD SHS | 200,000 | $197.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 710,000 | $195.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| DNABSocial Capital Suvretta Holdings Corp. II | CLASS A ORD SHS | 200,000 | $194.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| DNADSocial Capital Suvretta Holdings Corp. IV | CLASS A ORD SHS | 200,000 | $194.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SCYXScynexis Inc | COM NEW | 959,524 | $178.5 萬 | <0.1% | +415,481+76.4% | 加碼 | 歷史 |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 950,000 | $119.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 430,000 | $86.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 99,999 | $2.80 萬 | <0.1% | 00.0% | 不變 | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 57,770 | $1.00 萬 | <0.1% | 00.0% | 不變 | – |
2022 年第 1 季之後清倉（19 檔）
2022 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 1 季股數 | 2022 年第 1 季市值 | 2022 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| MRKMerck & Co., Inc. | Stock | 2,370,000 | $1.94 億 | 4.3% | 歷史 |
| BAXBaxter International Inc | Stock | 1,915,500 | $1.49 億 | 3.3% | 歷史 |
| BHVNBiohaven Ltd. | COM | 1,231,000 | $1.46 億 | 3.2% | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 1,393,000 | $1.15 億 | 2.5% | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 325,000 | $9,805 萬 | 2.2% | 歷史 |
| ACETAdicet Bio, Inc. | COM | 3,120,000 | $6,231 萬 | 1.4% | 歷史 |
| EWEdwards Lifesciences Corp | Stock | 440,000 | $5,180 萬 | 1.1% | 歷史 |
| BHCBausch Health Companies Inc. | Stock | 1,694,700 | $3,872 萬 | 0.9% | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 1,354,539 | $3,183 萬 | 0.7% | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 1,175,000 | $2,946 萬 | 0.7% | – |
| AXSMAxsome Therapeutics, Inc. | COM | 711,000 | $2,943 萬 | 0.7% | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 912,000 | $2,878 萬 | 0.6% | 歷史 |
| PENPenumbra Inc | COM | 104,000 | $2,310 萬 | 0.5% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,040,000 | $1,923 萬 | 0.4% | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 291,184 | $1,860 萬 | 0.4% | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 215,000 | $1,333 萬 | 0.3% | 歷史 |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $493.5 萬 | 0.1% | – |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $444.0 萬 | 0.1% | 歷史 |
| GRTSGritstone bio, Inc. | COM | 560,000 | $230.7 萬 | 0.1% | 歷史 |